 |
MorphoSys AG
MOR
|
18.2 |
- |
2.43 % |
$ 254 M |
Germany |
 |
Aptorum Group Limited
APM
|
0.91 |
$ 0.88 |
-1.69 % |
$ 6.47 M |
China |
 |
Aquestive Therapeutics
AQST
|
4.37 |
$ 4.1 |
- |
$ 438 M |
USA |
 |
AgeX Therapeutics
AGE
|
13 |
- |
-10.17 % |
$ 12.2 K |
USA |
 |
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
133 |
$ 9.59 |
- |
$ 620 M |
USA |
 |
I-Mab
IMAB
|
0.68 |
- |
- |
$ 866 M |
China |
 |
Akero Therapeutics
AKRO
|
48.4 |
- |
- |
$ 3.67 B |
USA |
 |
Midatech Pharma plc
MTP
|
0.29 |
- |
-18.52 % |
$ 27.3 M |
Britain |
 |
AlloVir
ALVR
|
9.78 |
- |
4.14 % |
$ 49.1 M |
USA |
 |
Biophytis SA
BPTS
|
0.33 |
- |
-13.47 % |
$ 169 M |
France |
 |
Genfit SA
GNFT
|
3.36 |
- |
2.54 % |
$ 160 B |
France |
 |
Burford Capital Limited
BUR
|
10.6 |
$ 4.92 |
- |
$ 781 M |
Britain |
 |
ACADIA Pharmaceuticals
ACAD
|
19.3 |
$ 22.45 |
- |
$ 3.72 B |
USA |
 |
Cerus Corporation
CERS
|
2.6 |
$ 2.03 |
- |
$ 387 M |
USA |
 |
Athira Pharma
ATHA
|
0.42 |
- |
- |
$ 269 M |
USA |
 |
Applied Molecular Transport
AMTI
|
0.57 |
- |
- |
$ 10.1 M |
USA |
 |
Ayala Pharmaceuticals
AYLA
|
0.5 |
- |
- |
$ 7.46 M |
Israel |
 |
AstraZeneca PLC
AZN
|
74.2 |
- |
- |
$ 96.9 B |
Britain |
 |
Atreca
BCEL
|
1.27 |
- |
-11.76 % |
$ 5.79 M |
USA |
 |
Berkeley Lights
BLI
|
1.7 |
- |
-7.31 % |
$ 87 M |
USA |
 |
Calithera Biosciences
CALA
|
13.3 |
- |
-10.95 % |
$ 876 K |
USA |
 |
Advaxis
ADXS
|
0.31 |
- |
-9.65 % |
$ 45.9 M |
USA |
 |
CymaBay Therapeutics
CBAY
|
32.3 |
- |
- |
$ 3.45 B |
USA |
 |
ChemoCentryx
CCXI
|
26.9 |
- |
- |
$ 3.74 B |
USA |
 |
Caladrius Biosciences
CLBS
|
0.43 |
- |
-16.75 % |
$ 25.8 M |
USA |
 |
Checkmate Pharmaceuticals
CMPI
|
2.44 |
- |
- |
$ 231 M |
USA |
 |
Aeterna Zentaris
AEZS
|
5.72 |
- |
5.93 % |
$ 314 M |
Canada |
 |
BioNTech SE
BNTX
|
91.2 |
$ 103.45 |
- |
$ 27.2 B |
Germany |
 |
Brainstorm Cell Therapeutics
BCLI
|
1.26 |
- |
-2.5 % |
$ 5.88 M |
USA |
 |
Aeglea BioTherapeutics
AGLE
|
12 |
- |
- |
$ 1.01 B |
USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
0.3 |
- |
- |
$ 26.5 M |
USA |
 |
Deciphera Pharmaceuticals
DCPH
|
14.1 |
- |
- |
$ 2.18 B |
USA |
 |
AIkido Pharma
AIKI
|
3.17 |
- |
1.93 % |
$ 17.4 M |
USA |
 |
Editas Medicine
EDIT
|
2.32 |
$ 3.0 |
- |
$ 266 M |
USA |
 |
Innate Pharma S.A.
IPHA
|
1.41 |
$ 1.44 |
-3.36 % |
$ 235 M |
France |
 |
Dynavax Technologies Corporation
DVAX
|
13.3 |
- |
- |
$ 2.02 B |
USA |
 |
Akouos
AKUS
|
5.34 |
- |
0.23 % |
$ 488 M |
USA |
 |
Allakos
ALLK
|
1.31 |
- |
- |
$ 28.6 M |
USA |
 |
Evogene Ltd.
EVGN
|
0.81 |
$ 0.78 |
- |
$ 27.9 M |
Israel |
 |
Edesa Biotech
EDSA
|
1.9 |
$ 18.27 |
- |
$ 58.4 M |
USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
2.92 |
$ 3.19 |
1.27 % |
$ 5.25 M |
Israel |
 |
Eiger BioPharmaceuticals
EIGR
|
2.11 |
- |
-9.21 % |
$ 2.55 M |
USA |
 |
Eloxx Pharmaceuticals
ELOX
|
2.84 |
- |
-5.68 % |
$ 8.28 M |
USA |
 |
CureVac N.V.
CVAC
|
19.3 |
- |
- |
$ 867 M |
Germany |
 |
Ampio Pharmaceuticals
AMPE
|
0.82 |
- |
-11.43 % |
$ 502 K |
USA |
 |
Applied Therapeutics
APLT
|
6.42 |
- |
- |
$ 8.42 M |
USA |
 |
Aptose Biosciences
APTO
|
3.32 |
- |
-45.71 % |
$ 1.2 M |
Canada |